本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Castle Biosciences, Inc.

16.32
-0.4000-2.39%
盘后16.320.00000.00%16:41 EDT
成交量:45.74万
成交额:751.09万
市值:4.71亿
市盈率:-88.47
高:16.93
开:16.72
低:16.16
收:16.72
数据加载中...
2025/06/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/23

重要事件披露

Form 8-K - Current report
2025/05/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/05/05

重要事件披露

Form 8-K - Current report
2025/04/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/27

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/02/27

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/27

重要事件披露

Form 8-K - Current report
2025/02/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/13

重要事件披露

Form 8-K - Current report
2025/01/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/04

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/04

重要事件披露

Form 8-K - Current report